PrimeraDx
Latest round
- Series C
Last raised
- Sep 2009
Total raised
- $54M
Investors
- 7
About PrimeraDx
PrimeraDx Inc.PrimeraDx Inc. specializes in molecular diagnostics, providing tools for genetic testing. Founded in 2004 and headquartered in Mansfield, Massachusetts, US, the company has successfully completed 8 deals.PrimeraDx specializes in molecular diagnostics, particularly through its innovative quantitative multiplex PCR technology. The company's core product offerings focus on providing comprehensive solutions for genetic testing, enabling healthcare professionals to diagnose various diseases with high precision and speed. These products are designed to address critical needs in areas such as oncology, infectious diseases, and inherited genetic disorders. The end users primarily include hospitals, clinical laboratories, and research institutions that seek reliable testing methods to enhance patient outcomes.PrimeraDx generates revenue through a structured business model that encompasses direct sales to healthcare providers and partnerships with clinical laboratories. Transactions typically involve the sale of diagnostic testing kits, which are purchased in bulk by hospitals and labs, facilitating their ability to offer advanced genetic testing services to patients. The company offers various pricing plans that reflect the complexity and specificity of its flagship products, including proprietary multiplex PCR assays. These plans are tailored to meet the needs of different customers, ensuring that healthcare facilities can access essential diagnostic tools while maintaining cost efficiency.In June 2014, Qiagen acquired PrimeraDx Inc. The financial terms of the deal were not disclosed. This acquisition indicates a strategic move towards expanding PrimeraDx's reach in the molecular diagnostics market.
Who invested in PrimeraDx
7 investors across 4 rounds
See all investors in PrimeraDx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PrimeraDx
Who invested in PrimeraDx?
PrimeraDx has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PrimeraDx raised?
PrimeraDx has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did PrimeraDx last raise money?
PrimeraDx's most recent round on record is a Series C, in Sep 2009.
What does PrimeraDx do?
PrimeraDx is a biotechnology company.
Where is PrimeraDx headquartered?
PrimeraDx is headquartered in Mansfield, US.
Which VCs invest in companies like PrimeraDx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at PrimeraDx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like PrimeraDx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.